The Global Report Positron Emission Tomography Market in terms of revenue was estimated to be worth $2.5 billion in 2023 and is poised to reach $3.5 billion by 2028, growing at a CAGR of 6.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The increasing number of research grants, rising prevalence of chronic diseases, and rising focus on precision medicine are expected to drive the market during the forecast period.

The positron emission tomography (PET) industry is poised for remarkable advancements in the near future. As a non-invasive imaging technique, PET plays a vital role in diagnosing and monitoring various diseases, including cancer, cardiovascular conditions, and neurological disorders. In the coming years, we can expect significant developments in PET technology, leading to improved image resolution, faster scanning times, and enhanced diagnostic accuracy. Advancements in radiotracer production and the emergence of novel radiopharmaceuticals will expand the range of applications for PET imaging, enabling more precise disease characterization and treatment planning. Additionally, the integration of PET with other imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), will provide comprehensive and multi-dimensional insights into complex medical conditions. The growing demand for personalized medicine and targeted therapies will drive the adoption of PET imaging as an essential tool for patient-specific treatment strategies. Furthermore, advancements in data analysis and artificial intelligence (AI) algorithms will facilitate better image interpretation and quantitative analysis, enabling more precise and reliable clinical decision-making. As research and development efforts continue to accelerate, the PET industry is poised to revolutionize disease diagnosis, monitoring, and treatment, ultimately improving patient outcomes and transforming the future of healthcare.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46142162

Browse in-depth TOC on "Positron Emission Tomography Market"

111 - Tables
36 - Figures
173 – Pages

Key Market Players:

As of 2022, prominent players in the positron emission tomography market are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Canon Inc. (Japan), Shanghai United Imaging Healthcare Co., Ltd (China), and Shimadzu Corporation (Japan).

Positron Emission Tomography Market Dynamics:

Drivers:

Growing adoption of multimodal PET imaging devices
Restraints:

High Capital and operational costs
Opportunities:

Increase in PET utilization for the detection of breast cancer
Challenges:

Availability of alternate imaging technologies
PET/CT segment of the global positron emission tomography market to register significant growth rate over the forecast period of 2023-2028

Based on the product, the global market is segmented into Standalone PET syetems, PET/CT systems, and PET/MRI systems. The PET/CT segment is anticipated to register the highest growth rate over the forecast period. The PET/CT segment accounted for the highest share of the positron emission tomography market in 2022.

Oncology segment accounted for the largest share of the positron emission tomography market, by application in 2022.

Based on application, the global market is segmented into oncology, cardiology, neurology and other applications. Oncology applications accounted for the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period. Factors such as the rising incidence of cancer cases, the growing geriatric population, and the launch of integrated modalities drive the growth of PET products.

The hospital and surgical centers segment accounted for the largest share of the positron emission tomography market, by end user, in 2022

Based on end user, the global positron emission tomography market is segmented into hospitals and surgical centers, diagnostic and imaging clinics, ambulatory surgery centers, and other end users. The hospital and surgical centers segment accounts for the largest share of the market in 2022. Factors attributing to the share of this particular are increasing funds and rising healthcare expenditure for the expansion of healthcare infrastructure are driving the growth of this segment.

The Asia Pacific market to register the highest growth in the market during the forecast period

The Asia Pacific positron emission tomography market is estimated to register the highest growth from 2023 to 2028. The top and major players in the market are expanding their manufacturing facilities in the regions of APAC. This region is having a rise in healthcare investment and expenditure, offering significant growth opportunities for the key players.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46142162

Recent Developments:

In May 2021, Zionexa, a top innovator in in-vivo biomarkers for oncology and neurology, has been acquired by GE Healthcare. This acquisition will enable GE Healthcare to advance Zionexa's pipeline biomarkers, as well as the recently FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18). Cerianna can be used in conjunction with biopsy to detect estrogen receptor (ER) positive lesions, providing valuable information for treatment selection in patients with recurrent or metastatic breast cancer. The aim is to bring these biomarkers to market and promote more personalized healthcare.
In February 2023, United Imaging, a renowned global leader in advanced medical imaging and radiotherapy equipment, participated as a Platinum partner at Arab Health 2023 held in Dubai, UAE from January 30 to February 2. They showcased an extensive range of cutting-edge medical imaging devices including the HD TOF PET/MR uPMR 790, which is capable of producing high-quality images; the uCT 960+, a 16cm detector/640 slice CT scanner that is the fastest cardiac CT scanner in the world; the uMI 780, an ultra-fast high-resolution digital PET/CT scanner; the uMR 680, a 1.5T Wide Bore MRI System with "3T-like" performance, powered by uAiFI; and the uDR 380i Pro, the most compact mobile DR system.
In May 2022, Mediso Ltd has recently acquired Bartec Technologies Ltd, a UK-based company that specializes in providing and supporting Nuclear Medicine and Molecular Imaging equipment and accessories.
Report Link: Positron Emission Tomography Market

TABLE OF CONTENTS:

1 INTRODUCTION (Page No. - 23)

STUDY OBJECTIVES
MARKET DEFINITION
MARKETS COVERED
MARKET SEGMENTATION
GEOGRAPHIC SEGMENTATION
YEARS CONSIDERED
CURRENCY CONSIDERED
RESEARCH METHODOLOGY (Page No. - 27)
RESEARCH DATA
RECESSION IMPACT
MARKET SIZE ESTIMATION
EXECUTIVE SUMMARY (Page No. - 41)
FIGURE 10 POSITRON EMISSION TOMOGRAPHY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)

FIGURE 11 POSITRON EMISSION TOMOGRAPHY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)

FIGURE 12 POSITRON EMISSION TOMOGRAPHY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)

FIGURE 13 GEOGRAPHICAL SNAPSHOT: POSITRON EMISSION TOMOGRAPHY MARKET

PREMIUM INSIGHTS (Page No. - 44)
POSITRON EMISSION TOMOGRAPHY MARKET OVERVIEW
FIGURE 14 RISING PREVALENCE OF TARGET DISEASES TO DRIVE GROWTH

NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY MARKET, BY PRODUCT (USD MILLION)
ASIA PACIFIC: POSITRON EMISSION TOMOGRAPHY MARKET, BY END USER (USD MILLION)